These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6126778)

  • 21. [Phenotype change in hyperlipoproteinemias].
    Meincke H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):236-9. PubMed ID: 4085393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary hyperlipoproteinemia type IV and V in 3 young children].
    Karczewska K; Bobilewicz D; Kasner J; Smigla K; Torbus O; Sliwa F
    Pediatr Pol; 1980 Dec; 55(12):1331-9. PubMed ID: 7243406
    [No Abstract]   [Full Text] [Related]  

  • 23. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.
    Charrière S; Cugnet C; Guitard M; Bernard S; Groisne L; Charcosset M; Pruneta-Deloche V; Merlin M; Billon S; Delay M; Sassolas A; Moulin P; Marçais C
    Atherosclerosis; 2009 Nov; 207(1):150-6. PubMed ID: 19447388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Connections between apolipoprotein E genotypes and the development of cardiovascular diseases].
    Végh C; Langmár Z; Szerző M; Agota A; Marosi K; Szabolcs Z; Nagy ZB
    Orv Hetil; 2012 Dec; 153(52):2070-6. PubMed ID: 23261995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.
    Evans D; Seedorf U; Beil FU
    Clin Genet; 2005 Oct; 68(4):369-72. PubMed ID: 16143024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Familial combined hyperlipemia in childhood].
    Guardamagna O; Bondone C; Allora C; Sacchetti C; Rabbone I
    Pediatr Med Chir; 2002; 24(4):257-66. PubMed ID: 12197082
    [No Abstract]   [Full Text] [Related]  

  • 29. Apolipoprotein E2/E2 genotype in combination with mutations in the LDL receptor gene causes type III hyperlipoproteinemia.
    Geisel J; Bunte T; Bodis M; Oette K; Herrmann W
    Clin Chem Lab Med; 2002 May; 40(5):475-9. PubMed ID: 12113291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
    Rall SC; Weisgraber KH; Innerarity TL; Mahley RW
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4696-700. PubMed ID: 6289314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apolipoprotein E polymorphism, hyperlipidemia and risk of myocardial infarct].
    Assmann G; Lenzen HJ
    Internist (Berl); 1985 Nov; 26(11):692-700. PubMed ID: 3908375
    [No Abstract]   [Full Text] [Related]  

  • 34. [Primary hyperlipoproteinemia in childhood (author's transl)].
    Bosch Banyeras JM; Frisón J; Salcedo S; Moraga F
    An Esp Pediatr; 1981 Apr; 14(4):264-6. PubMed ID: 7283288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of apolipoprotein variants.
    Menzel HJ; Utermann G
    Prog Clin Biol Res; 1988; 255():63-72. PubMed ID: 2963348
    [No Abstract]   [Full Text] [Related]  

  • 37. Apolipoprotein E polymorphism and hyperlipoproteinemia in obesity.
    Eto M; Watanabe K; Ishii K
    Int J Obes; 1989; 13(4):433-40. PubMed ID: 2793298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation.
    Utermann G; Albrecht G; Steinmetz A
    Clin Genet; 1978 Dec; 14(6):351-8. PubMed ID: 215358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Ben-Shlomo Y; Lewis G; McKeigue PM
    Lancet; 1993 Nov; 342(8882):1310. PubMed ID: 7901626
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization with zonal ultracentrifugation of low-density lipoproteins in type V hyperlipoproteinemia.
    Manzato E; Gasparotto A; Marin R; Baggio G; Baldo G; Crepaldi G
    Biochim Biophys Acta; 1984 May; 793(3):365-71. PubMed ID: 6712974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.